What is Oruka Therapeutics, Inc.'s net investment in lease?

Oruka Therapeutics, Inc. (ORKA) reported net investment in lease of $1.69M in Q1 2026.

How has Oruka Therapeutics, Inc.'s net investment in lease changed year-over-year?

Oruka Therapeutics, Inc.'s net investment in lease increased by 107.2% year-over-year, from $814K to $1.69M.

What is the long-term trend for Oruka Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s net investment in lease has grown at a 33.7% compound annual growth rate (CAGR), from $428K to $1.83M.

Oruka Therapeutics, Inc. ORKA Net Investment in Lease

Net Investment in Lease at other companies

Kymera TherapeuticsKYMR

——

Protagonist TherapeuticsPTGX

——

Alumis Inc.ALMS

——

Arcutis Biotherapeutics, Inc.ARQT

——

Erasca, Inc.ERAS

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s net investment in lease?: Oruka Therapeutics, Inc. (ORKA) reported net investment in lease of $1.69M in Q1 2026.
How has Oruka Therapeutics, Inc.'s net investment in lease changed year-over-year?: Oruka Therapeutics, Inc.'s net investment in lease increased by 107.2% year-over-year, from $814K to $1.69M.
What is the long-term trend for Oruka Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s net investment in lease has grown at a 33.7% compound annual growth rate (CAGR), from $428K to $1.83M.